Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.
Precipio Diagnostics has raised $500K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2024.
Precipio Diagnostics's investors include Connecticut Innovations, Ironwood Capital, Advantage Capital, Enhanced Capital Partners, Kuzari Group.
Precipio Diagnostics is headquartered in New Haven, United States.
Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.
Precipio Diagnostics is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Precipio Diagnostics — Funding & Investors." VCBacked, May 6, 2024, https://www.vcbacked.co/company/precipio-diagnostics. Accessed July 19, 2026.
VCBacked. (2024). Precipio Diagnostics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/precipio-diagnostics
{{cite web |title=Precipio Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/precipio-diagnostics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated